DRW Securities’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,300
Closed -$498K 1430
2025
Q2
$498K Buy
1,300
+400
+44% +$144K 0.01% 491
2025
Q1
$311K Sell
900
-500
-36% -$161K 0.01% 417
2024
Q4
$420K Sell
1,400
-20
-1% -$6.99K 0.01% 363
2024
Q3
$577K Sell
1,420
-153
-10% -$56K 0.02% 351
2024
Q2
$503K Buy
+1,573
New +$511K 0.02% 326
2023
Q4
Sell
-6,700
Closed -$1.65M 378
2023
Q3
$1.65M Buy
+6,700
New +$1.83M 0.03% 102
2022
Q4
Sell
-1,950
Closed -$358K 294
2022
Q3
$358K Buy
+1,950
New +$388K 0.01% 169
2022
Q2
Sell
-799
Closed -$200K 287
2022
Q1
$200K Buy
+799
New +$201K 0.01% 258
2021
Q3
Sell
-1,012
Closed -$209K 309
2021
Q2
$209K Buy
+1,012
New +$206K 0.01% 276
2018
Q1
Sell
-3,960
Closed -$348K 308
2017
Q4
$348K Buy
+3,960
New +$318K 0.04% 285

Other funds holding HCA

DRW Securities's HCA Position: Q3 2025 in Review

DRW Securities sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 1,300 shares — an estimated $498K sold.

DRW Securities first reported a position in HCA in Q4 2017 and held it in 10 quarters. The position peaked at $1.65M in Q3 2023. 1,286 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • DRW Securities reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
  • DRW Securities sold 1,300 HCA Healthcare shares in Q3 2025, an estimated $498K.
  • DRW Securities first reported a position in HCA Healthcare in Q4 2017 and held it in 10 quarters.
  • DRW Securities's HCA Healthcare position peaked at $1.65M in Q3 2023.
  • 1,286 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.